Michael Kyriakides
Director/Board Member at Purespring Therapeutics Ltd.
Michael Kyriakides active positions
| Companies | Position | Start | End |
|---|---|---|---|
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 31/07/2018 | - |
Purespring Therapeutics Ltd.
 Purespring Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Purespring Therapeutics Ltd. provides biotechnological research and experimental development services. The company was founded on April 1, 2020 and is headquartered in London, the United Kingdom. | Director/Board Member | 31/03/2022 | - |
Career history of Michael Kyriakides
Training of Michael Kyriakides
| Imperial College London | Doctorate Degree |
Statistics
International
| United Kingdom | 4 |
Operational
| Doctorate Degree | 2 |
| Undergraduate Degree | 2 |
| Private Equity Investor | 1 |
Sectoral
| Finance | 2 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Finance |
Purespring Therapeutics Ltd.
Purespring Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Purespring Therapeutics Ltd. provides biotechnological research and experimental development services. The company was founded on April 1, 2020 and is headquartered in London, the United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- Michael Kyriakides
- Experience
